课题基金 / 基金详情

NOVEL FUNCTIONS OF THE AH RECEPTOR

NOVEL FUNCTIONS OF THE AH RECEPTOR
AH 受体的新功能
批准号:
6150734
负责人:
JOHN J REINERS
金额:
$24.99万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-02-01 至 2002-01-31

项目摘要

项目成果

JOHN J REINERS的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The aryl hydrocarbon receptor (AHR) is a ligand-activated transcription factor. The effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and many polycyclic aromatic hydrocarbons. (PAHs) are thought to be mediated by their binding to the AHR and a subsequent cascade of events including: association of the AHR with the aryl hydrocarbon receptor nuclear translocator (ARNT) protein, binding of the resultant heterodimer to enhancer sequencers in target genes, and transcriptional activation of the target genes. An unresolved issue in the AHR field is whether the AHR has activities independent of its function as a ligand-activated transcription factor. In recent studies employing murine hepatoma cells engineered to have different AHR contents we observed in direct correlation between AHR content and susceptibility to induction of apoptosis by ceramide, but not staurosporin or doxorubicin. Ceramide did not function as an AHR ligand. Furthermore, unlike all known AHR-mediated processes, susceptibility to ceramide-induced apoptosis did not require a functional ARNT. Based upon these observation we hypothesize that the AHR is a modulator of ceramide signaling, and does so by a process that is independent of it function is a ligand-activated, ARNT-associated transcription factor. In this application we propose to determine if the AHR content-dependent resources we noted are 1) seen in a variety of cell/tissue types having varied AHR contents; 2) reflect the differential expression of pro- and anti- apoptotic proteins. In addition, 4) we will use transfection analyses and truncated or mutated forms of the AHR to determine the regions/functions (e.g., DNA and ligand/binding, heterodimerization, transactivation, etc.) of the AHR important in the modulation of ceramide-induced apoptosis. These studies will establish whether we have identified a novel function for the AHR, and a new modulator of ceramide-mediated signaling. Such information is important to the areas of development, autoimmunity and cancer ontogeny and treatment since induction of apoptosis by many chemotherapeutic agents appears to ceramide-dependent, and AHR expression is tightly regulated during embryonic development and immune cell differentiation and activation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CORE--Cell Signaling Research Core
  • 批准号:
    6750894
  • 项目类别:
  • 资助金额:
    $4.11万
  • 财政年份:
    2004
  • 负责人:
    JOHN J REINERS
  • 依托单位:
Training Program in Molecular and Cellular Toxicology
  • 批准号:
    6766910
  • 项目类别:
  • 资助金额:
    $6.41万
  • 财政年份:
    2003
  • 负责人:
    JOHN J REINERS
  • 依托单位:
Training Program in Molecular and Cellular Toxicology
  • 批准号:
    6593640
  • 项目类别:
  • 资助金额:
    $6.13万
  • 财政年份:
    2003
  • 负责人:
    JOHN J REINERS
  • 依托单位:
Training Program in Molecular and Cellular Toxicology
  • 批准号:
    7256244
  • 项目类别:
  • 资助金额:
    $5.91万
  • 财政年份:
    2003
  • 负责人:
    JOHN J REINERS
  • 依托单位:
国内基金
海外基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    郑绪阳
  • 依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2017
  • 负责人:
    卫高菲
  • 依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2016
  • 负责人:
    陈昊
  • 依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 项目类别:
    面上项目
  • 资助金额:
    73.0万元
  • 批准年份:
    2014
  • 负责人:
    董家鸿
  • 依托单位: